Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung

Background: Lung adenocarcinoma (LUAD) is a heterogeneous disease with high mortality. Close attention has been paid to immunotherapy in LUAD treatment. However, immunotherapy has produced different therapeutic effects because of immune heterogeneity. Long noncoding RNAs (lncRNAs) are survival progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Huikai, Chen, Dongni, Li, Rongzhen, Hu, Jia, Chen, Youfang, Xu, Chunmei, Wen, Zhesheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791552/
https://www.ncbi.nlm.nih.gov/pubmed/33324975
http://dx.doi.org/10.1042/BSR20202444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791552/
https://www.ncbi.nlm.nih.gov/pubmed/33324975
http://dx.doi.org/10.1042/BSR20202444

Ejemplares similares